Shubham Atal

1.2k total citations
54 papers, 462 citations indexed

About

Shubham Atal is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Infectious Diseases. According to data from OpenAlex, Shubham Atal has authored 54 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 8 papers in Infectious Diseases. Recurrent topics in Shubham Atal's work include Diabetes Management and Research (8 papers), Diabetes Treatment and Management (8 papers) and COVID-19 Clinical Research Studies (7 papers). Shubham Atal is often cited by papers focused on Diabetes Management and Research (8 papers), Diabetes Treatment and Management (8 papers) and COVID-19 Clinical Research Studies (7 papers). Shubham Atal collaborates with scholars based in India, United States and Switzerland. Shubham Atal's co-authors include Balakrishnan Sadasivam, Savita Vyas, Rajendra Agrawal, Rajnish Joshi, Santenna Chenchula, Avik Ray, Ratinder Jhaj, Chakradhara Rao S. Uppugunduri, Ankur Joshi and Sakshi Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Virology and BMJ Open.

In The Last Decade

Shubham Atal

45 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shubham Atal India 10 124 74 61 60 54 54 462
Monika Tandon India 11 172 1.4× 42 0.6× 59 1.0× 80 1.3× 78 1.4× 25 415
Mohammad Fathalipour Iran 15 195 1.6× 27 0.4× 40 0.7× 115 1.9× 72 1.3× 43 648
Mina Kelleni Egypt 10 109 0.9× 34 0.5× 46 0.8× 118 2.0× 56 1.0× 33 434
Balakrishnan Sadasivam India 11 174 1.4× 17 0.2× 79 1.3× 73 1.2× 56 1.0× 43 512
Christopher Wai‐Kei Lam Hong Kong 12 153 1.2× 124 1.7× 18 0.3× 91 1.5× 45 0.8× 12 784
Meghan J. Arwood United States 12 88 0.7× 178 2.4× 41 0.7× 88 1.5× 16 0.3× 23 461
Carmela Santuccio Italy 11 68 0.5× 124 1.7× 13 0.2× 63 1.1× 81 1.5× 21 706
Marco Cantù Italy 10 240 1.9× 20 0.3× 57 0.9× 114 1.9× 45 0.8× 22 663
Shukui Wang China 10 156 1.3× 116 1.6× 109 1.8× 185 3.1× 46 0.9× 19 676
Ganesh Cherala United States 18 72 0.6× 51 0.7× 82 1.3× 234 3.9× 27 0.5× 45 1.0k

Countries citing papers authored by Shubham Atal

Since Specialization
Citations

This map shows the geographic impact of Shubham Atal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shubham Atal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shubham Atal more than expected).

Fields of papers citing papers by Shubham Atal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shubham Atal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shubham Atal. The network helps show where Shubham Atal may publish in the future.

Co-authorship network of co-authors of Shubham Atal

This figure shows the co-authorship network connecting the top 25 collaborators of Shubham Atal. A scholar is included among the top collaborators of Shubham Atal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shubham Atal. Shubham Atal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chenchula, Santenna, et al.. (2025). Emerging variants of Mpox virus and tecovirimat resistance: Genomic insights and implications for treatment strategies. Virology. 608. 110532–110532. 3 indexed citations
2.
Atal, Shubham, et al.. (2024). Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions. Journal of Pharmacological and Toxicological Methods. 127. 107514–107514. 3 indexed citations
3.
Chenchula, Santenna, Shubham Atal, & Chakradhara Rao S. Uppugunduri. (2024). A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care. The Pharmacogenomics Journal. 24(2). 9–9. 20 indexed citations
4.
5.
6.
7.
8.
9.
Atal, Shubham, et al.. (2021). Patterns of drug therapy, glycemic control, and predictors of escalation – non-escalation of treatment among diabetes outpatients at a tertiary care center. Journal of Basic and Clinical Physiology and Pharmacology. 33(6). 803–814. 1 indexed citations
10.
11.
Atal, Shubham, et al.. (2021). Non -Union of Lateral Hoffa Fracture - A Case Report. Journal of Orthopaedic Case Reports. 11(1). 33–36. 4 indexed citations
12.
Sadasivam, Balakrishnan, et al.. (2020). Development and validation of a mathematical model to quantify antibiotic consumption in paediatric population: A hospital‐based pilot study. Journal of Clinical Pharmacy and Therapeutics. 45(6). 1349–1356. 2 indexed citations
13.
Atal, Shubham, et al.. (2020). Linagliptin: Cardiovascular and renal safety beyond doubt at a steep price. Journal of Pharmacology and Pharmacotherapeutics. 11(2). 35. 1 indexed citations
14.
Joshi, Rajnish, et al.. (2020). Diabetes care during COVID-19 lockdown at a tertiary care centre in India. Diabetes Research and Clinical Practice. 166. 108316–108316. 21 indexed citations
15.
16.
Najmi, Ahmad, Shubham Atal, Balakrishnan Sadasivam, Pooja Singh, & Avik Ray. (2019). Early onset gestational diabetes mellitus: A case report and importance of early screening. SHILAP Revista de lepidopterología. 8(5). 1772–1772. 1 indexed citations
17.
Atal, Shubham, et al.. (2019). Medication concordance in modern medicine – A critical appraisal from an Indian perspective. SHILAP Revista de lepidopterología. 8(4). 1313–1313. 9 indexed citations
18.
Atal, Shubham, et al.. (2016). STUDY TO EVALUATE THE ROLE OF SEROTONIN IN PARKINSONIAN SYMPTOMS. International Journal of Pharmacy and Pharmaceutical Sciences. 8(7). 209–211. 1 indexed citations
19.
Atal, Shubham, et al.. (2016). COST ANALYSIS OF COMMONLY USED DRUGS UNDER PRICE CONTROL IN INDIA: ASSESSING THE EFFECT OF DRUG PRICE CONTROL ORDER ON BRAND PRICE VARIATION. International Journal of Pharmacy and Pharmaceutical Sciences. 8(4). 315–321. 16 indexed citations
20.
Atal, Shubham, et al.. (2016). EVALUATION OF ANTIANXIETY, ANTIDEPRESSANT AND SEDATIVE EFFECTS OF NIMODIPINE IN SWISS ALBINO MICE. International Journal of Pharmacy and Pharmaceutical Sciences. 8(6). 260–263. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monika Tandon Breakdown of academic impact, for papers by Mohammad Fathalipour Breakdown of academic impact, for papers by Mina Kelleni Breakdown of academic impact, for papers by Balakrishnan Sadasivam Breakdown of academic impact, for papers by Christopher Wai‐Kei Lam Breakdown of academic impact, for papers by Meghan J. Arwood Breakdown of academic impact, for papers by Carmela Santuccio Breakdown of academic impact, for papers by Marco Cantù Breakdown of academic impact, for papers by Shukui Wang Breakdown of academic impact, for papers by Ganesh Cherala
Rankless by CCL
2026